Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Windlas Biotech Ltd.
Swot
Windlas Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Windlas Biotech Ltd. has 12 Strengths, 7 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(7)
Opportunity
(1)
Threats
(1)
Others
(4)
Benjamin Graham Value Screen
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Week
Increasing Revenue every Quarter for the past 8 Quarters
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Promoter decreasing their shareholding
Negative Breakdown First Support (LTP < S1)
PEG greater than Industry PEG
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
MFs decreased their shareholding last quarter
Rising Delivery Percentage Compared to Prev Day
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks